New Analyses Demonstrate Versatility and Continued Efficacy of TALVEY™ in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

Press/Media

Period11 Dec 2023 → 12 Dec 2023

Media coverage

179

Media coverage